Oxacephem
Class of pharmaceutical drugs
An oxacephem is a β-lactam molecule similar to a cephem, but with an oxygen substituted for the sulfur. They are synthetic compounds not seen in nature, generally used as β-lactam antibiotics. Examples include Latamoxef[1] and Flomoxef.[2][3]
References
- ^ "Medscape.com". Retrieved 2008-12-29.
- ^ Yazawa K, Mikami Y, Uno J, Otozai K, Arai T (December 1989). "In-vitro activity of flomoxef, a new oxacephem group antibiotic, against Nocardia in comparison with other cephalosporins". J. Antimicrob. Chemother. 24 (6): 921–5. doi:10.1093/jac/24.6.921. PMID 2621177.
- ^ Cazzola M, Brancaccio V, De Giglio C, Paternò E, Matera MG, Rossi F (March 1993). "Flomoxef, a new oxacephem antibiotic, does not cause hemostatic defects". Int J Clin Pharmacol Ther Toxicol. 31 (3): 148–52. PMID 8468113.
- v
- t
- e
(inhibit synthesis
of peptidoglycan
layer of bacterial
cell wall by binding
to and inhibiting
PBPs, a group of
D-alanyl-D-alanine
transpeptidases)
Glycopeptides Lipoglycopeptides |
|
---|---|
Lipopeptides |
|
Polymyxins |
|
Other |
|
- Inhibit PG subunit synthesis and transport: NAM synthesis inhibition (Fosfomycin)
- DADAL/AR inhibitors (Cycloserine)
- bactoprenol inhibitors (Bacitracin)
- Hydrolyze NAM-NAG
- Tyrothricin
- Isoniazid#
- Teixobactin
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e